DOCSLIB.ORG

Gene Id Function Fig|6666666.284511.Peg.1 Carbamoyl-Phosphate Synthase Large Chain (EC 6.3.5.5) Fig|6666666.284511.Peg.2 Carbamo

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gene Id Function Fig|6666666.284511.Peg.1 Carbamoyl-Phosphate Synthase Large Chain (EC 6.3.5.5) Fig|6666666.284511.Peg.2 Carbamo Gene id function fig|6666666.284511.peg.1 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.2 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.3 hypothetical protein fig|6666666.284511.peg.4 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.5 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.6 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.7 hypothetical protein fig|6666666.284511.peg.8 Transcription elongation factor GreA fig|6666666.284511.peg.9 hypothetical protein fig|6666666.284511.peg.10 hypothetical protein fig|6666666.284511.peg.11 hypothetical protein fig|6666666.284511.peg.12 hypothetical protein fig|6666666.284511.peg.13 Transcription elongation factor GreA fig|6666666.284511.peg.14 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.15 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.16 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.17 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.18 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.19 hypothetical protein fig|6666666.284511.peg.20 Mobile element protein fig|6666666.284511.peg.21 hypothetical protein fig|6666666.284511.peg.22 hypothetical protein fig|6666666.284511.peg.23 hypothetical protein fig|6666666.284511.peg.24 Mobile element protein fig|6666666.284511.peg.25 hypothetical protein fig|6666666.284511.peg.26 Mobile element protein fig|6666666.284511.peg.27 Lead, cadmium, zinc and mercury transporting ATPase (EC 3.6.3.3) (E fig|6666666.284511.peg.28 Mobile element protein fig|6666666.284511.peg.29 hypothetical protein fig|6666666.284511.peg.30 hypothetical protein fig|6666666.284511.peg.31 hypothetical protein fig|6666666.284511.peg.32 Mobile element protein fig|6666666.284511.peg.33 hypothetical protein fig|6666666.284511.peg.34 hypothetical protein fig|6666666.284511.peg.35 Probable transmembrane protein fig|6666666.284511.peg.36 hypothetical protein fig|6666666.284511.peg.37 Chloride channel protein fig|6666666.284511.peg.38 hypothetical protein fig|6666666.284511.peg.39 hypothetical protein fig|6666666.284511.peg.40 5-nucleotidase SurE (EC 3.1.3.5) fig|6666666.284511.peg.41 Protein-L-isoaspartate O-methyltransferase (EC 2.1.1.77) fig|6666666.284511.peg.42 Lipoprotein NlpD fig|6666666.284511.peg.43 RNA polymerase sigma factor RpoS fig|6666666.284511.peg.44 Polysaccharide biosynthesis protein WlaX fig|6666666.284511.peg.45 23S rRNA (Uracil-5-) -methyltransferase RumA (EC 2.1.1.-) fig|6666666.284511.peg.46 hypothetical protein fig|6666666.284511.peg.47 Putative TEGT family carrier/transport protein fig|6666666.284511.peg.48 Ferric siderophore transport system, periplasmic binding protein Ton fig|6666666.284511.peg.49 hypothetical protein fig|6666666.284511.peg.50 Carbamoyl-phosphate synthase small chain (EC 6.3.5.5) fig|6666666.284511.peg.51 L-lysine permease fig|6666666.284511.peg.52 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) fig|6666666.284511.peg.53 Transcription elongation factor GreA fig|6666666.284511.peg.54 Probable transmembrane protein fig|6666666.284511.peg.55 FIG004454: RNA binding protein fig|6666666.284511.peg.56 Heat shock protein FtsJ/RrmJ @ Ribosomal RNA large subunit methy fig|6666666.284511.peg.57 Cell division protein FtsH (EC 3.4.24.-) fig|6666666.284511.peg.58 Dihydropteroate synthase (EC 2.5.1.15) fig|6666666.284511.peg.59 Phosphoglucosamine mutase (EC 5.4.2.10) fig|6666666.284511.peg.60 Phosphate ABC transporter, periplasmic phosphate-binding protein P fig|6666666.284511.peg.61 Phosphate transport system permease protein PstC (TC 3.A.1.7.1) fig|6666666.284511.peg.62 Phosphate transport system permease protein PstA (TC 3.A.1.7.1) fig|6666666.284511.peg.63 Phosphate transport ATP-binding protein PstB (TC 3.A.1.7.1) fig|6666666.284511.peg.64 Phosphate transport system regulatory protein PhoU fig|6666666.284511.peg.65 Phosphate regulon transcriptional regulatory protein PhoB (SphR) fig|6666666.284511.peg.66 Polyphosphate kinase (EC 2.7.4.1) fig|6666666.284511.peg.67 Exopolyphosphatase (EC 3.6.1.11) fig|6666666.284511.peg.68 Putative hemolysin fig|6666666.284511.peg.69 Phosphohistidine phosphatase SixA fig|6666666.284511.peg.70 hypothetical protein fig|6666666.284511.peg.71 Spermidine synthase-like protein fig|6666666.284511.peg.72 Lysyl-tRNA synthetase (class II) (EC 6.1.1.6) fig|6666666.284511.peg.73 Glucose-6-phosphate isomerase (EC 5.3.1.9) fig|6666666.284511.peg.74 MgtC family fig|6666666.284511.peg.75 dTDP-glucose 4,6-dehydratase (EC 4.2.1.46) fig|6666666.284511.peg.76 dTDP-4-dehydrorhamnose reductase (EC 1.1.1.133) fig|6666666.284511.peg.77 Undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transfer fig|6666666.284511.peg.78 Cell division topological specificity factor MinE fig|6666666.284511.peg.79 Septum site-determining protein MinD fig|6666666.284511.peg.80 Septum site-determining protein MinC fig|6666666.284511.peg.81 hypothetical protein fig|6666666.284511.peg.82 Acyl-CoA dehydrogenase (EC 1.3.8.7) fig|6666666.284511.peg.83 hypothetical protein fig|6666666.284511.peg.84 Probable transmembrane protein fig|6666666.284511.peg.85 Lipoprotein releasing system transmembrane protein LolC fig|6666666.284511.peg.86 voltage-gated potassium channel beta subunit fig|6666666.284511.peg.87 Short chain dehydrogenase fig|6666666.284511.peg.88 Regulatory protein, RpfE type fig|6666666.284511.peg.89 Single-stranded-DNA-specific exonuclease RecJ (EC 3.1.-.-) fig|6666666.284511.peg.90 diguanylate cyclase/phosphodiesterase (GGDEF & EAL domains) with fig|6666666.284511.peg.91 Lipoprotein releasing system ATP-binding protein LolD fig|6666666.284511.peg.92 UDP-N-acetylglucosamine 4,6-dehydratase (EC 4.2.1.-) fig|6666666.284511.peg.93 Lipopolysaccharide biosynthesis protein RffA fig|6666666.284511.peg.94 transferase hexapeptide repeat fig|6666666.284511.peg.95 UDP-Bac2Ac4Ac hydrolyzing 2-epimerase NeuC homolog fig|6666666.284511.peg.96 N-acetylneuraminate synthase (EC 2.5.1.56) fig|6666666.284511.peg.97 Legionaminic acid cytidylyltransferase (EC 2.7.7.43) fig|6666666.284511.peg.98 hypothetical protein fig|6666666.284511.peg.99 hypothetical protein fig|6666666.284511.peg.100 Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) fig|6666666.284511.peg.101 Undecaprenyl-phosphate galactose phosphotransferase (EC 2.7.8.6) fig|6666666.284511.peg.102 HpcH/HpaI aldolase fig|6666666.284511.peg.103 virulence factor MVIN family protein fig|6666666.284511.peg.104 IncP-type DNA relaxase TraI fig|6666666.284511.peg.105 hypothetical protein fig|6666666.284511.peg.106 hypothetical protein fig|6666666.284511.peg.107 hypothetical protein fig|6666666.284511.peg.108 Hyphotheical protein fig|6666666.284511.peg.109 DNA primase domain protein fig|6666666.284511.peg.110 hypothetical protein fig|6666666.284511.peg.111 hypothetical protein fig|6666666.284511.peg.112 protein of unknown function DUF132 fig|6666666.284511.peg.113 hypothetical protein fig|6666666.284511.peg.114 Alpha-ribazole-5'-phosphate phosphatase (EC 3.1.3.73) fig|6666666.284511.peg.115 histidine triad (HIT) protein fig|6666666.284511.peg.116 conserved protein fig|6666666.284511.peg.117 Mobile element protein fig|6666666.284511.peg.118 MoxR-like ATPase in aerotolerance operon fig|6666666.284511.peg.119 hypothetical protein fig|6666666.284511.peg.120 hypothetical protein fig|6666666.284511.peg.121 BatA (Bacteroides aerotolerance operon) fig|6666666.284511.peg.122 TPR domain protein in aerotolerance operon fig|6666666.284511.peg.123 hypothetical protein fig|6666666.284511.peg.124 Integral membrane protein fig|6666666.284511.peg.125 Mg(2+) transport ATPase protein C fig|6666666.284511.peg.126 hypothetical protein fig|6666666.284511.peg.127 Cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79) fig|6666666.284511.peg.128 hypothetical protein fig|6666666.284511.peg.129 Enolase (EC 4.2.1.11) fig|6666666.284511.peg.130 MutS domain protein, family 5 fig|6666666.284511.peg.131 MutS domain protein, family 4 fig|6666666.284511.peg.132 hypothetical protein fig|6666666.284511.peg.133 Protein crcB homolog fig|6666666.284511.peg.134 Hydrogenase-4 component B / Formate hydrogenlyase subunit 3 fig|6666666.284511.peg.135 Formate hydrogenlyase subunit 7 fig|6666666.284511.peg.136 Ni,Fe-hydrogenase III large subunit fig|6666666.284511.peg.137 Hydrogenase-4 component F fig|6666666.284511.peg.138 Hydrogenase-4 component E fig|6666666.284511.peg.139 Formate hydrogenlyase subunit 4 fig|6666666.284511.peg.140 GGDEF domain protein fig|6666666.284511.peg.141 predicted cell surface protein/ lipoprotein fig|6666666.284511.peg.142 hypothetical protein fig|6666666.284511.peg.143 Conserved protein fig|6666666.284511.peg.144 Mobile element protein fig|6666666.284511.peg.145 hypothetical protein fig|6666666.284511.peg.146 [NiFe] hydrogenase metallocenter assembly protein HypE fig|6666666.284511.peg.147 [NiFe] hydrogenase metallocenter assembly protein HypD fig|6666666.284511.peg.148 Phosphoheptose isomerase (EC 5.3.1.-) fig|6666666.284511.peg.149 [NiFe] hydrogenase metallocenter assembly protein HypC fig|6666666.284511.peg.150 [NiFe] hydrogenase metallocenter assembly protein HypF fig|6666666.284511.peg.151 Uptake hydrogenase large subunit (EC 1.12.99.6) fig|6666666.284511.peg.152 Uptake hydrogenase small subunit precursor (EC 1.12.99.6) fig|6666666.284511.peg.153 Signal transduction histidine kinase HoxJ (hydrogenase regulation) fig|6666666.284511.peg.154
Load more

Recommended publications
  • Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications
    International Journal of Molecular Sciences Review Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications Daniel Fernández-Villa 1, Maria Rosa Aguilar 1,2 and Luis Rojo 1,2,* 1 Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas, CSIC, 28006 Madrid, Spain; [email protected] (D.F.-V.); [email protected] (M.R.A.) 2 Consorcio Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-915-622-900 Received: 18 September 2019; Accepted: 7 October 2019; Published: 9 October 2019 Abstract: Bacterial, protozoan and other microbial infections share an accelerated metabolic rate. In order to ensure a proper functioning of cell replication and proteins and nucleic acids synthesis processes, folate metabolism rate is also increased in these cases. For this reason, folic acid antagonists have been used since their discovery to treat different kinds of microbial infections, taking advantage of this metabolic difference when compared with human cells. However, resistances to these compounds have emerged since then and only combined therapies are currently used in clinic. In addition, some of these compounds have been found to have an immunomodulatory behavior that allows clinicians using them as anti-inflammatory or immunosuppressive drugs. Therefore, the aim of this review is to provide an updated state-of-the-art on the use of antifolates as antibacterial and immunomodulating agents in the clinical setting, as well as to present their action mechanisms and currently investigated biomedical applications. Keywords: folic acid antagonists; antifolates; antibiotics; antibacterials; immunomodulation; sulfonamides; antimalarial 1.
    [Show full text]
  • Purification, Crystallization and Preliminary X-Ray Diffraction Analysis of Exodeoxyribonuclease III from Crenarchaeon Sulfolobus Tokodaii Strain 7
    Crystal Structure Theory and Applications, 2013, 2, 155-158 Published Online December 2013 (http://www.scirp.org/journal/csta) http://dx.doi.org/10.4236/csta.2013.24021 Purification, Crystallization and Preliminary X-Ray Diffraction Analysis of Exodeoxyribonuclease III from Crenarchaeon Sulfolobus tokodaii Strain 7 Shuichi Miyamoto1*, Chieko Naoe2, Masaru Tsunoda3, Kazuo T. Nakamura2 1Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan 2School of Pharmacy, Showa University, Tokyo, Japan 3Faculty of Pharmacy, Iwaki Meisei University, Iwaki, Japan Email: *[email protected] Received October 13, 2013; revised November 12, 2013; accepted December 6, 2013 Copyright © 2013 Shuichi Miyamoto et al. This is an open access article distributed under the Creative Commons Attribution Li- cense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Exodeoxyribonuclease III (EXOIII) acts as a 3’→5’ exonuclease and is homologous to purinic/apyrimidinic (AP) en- donuclease (APE), which plays an important role in the base excision repair pathway. To structurally investigate the reaction and substrate recognition mechanisms of EXOIII, a crystallographic study of EXOIII from Sulfolobus tokodaii strain 7 was carried out. The purified enzyme was crystallized by using the hanging-drop vapor-diffusion method. The crystals belonged to space group C2, with unit-cell parameters a = 154.2, b = 47.7, c = 92.4 Å, β = 125.8˚ and diffracted to 1.5 Å resolution. Keywords: Crenarchaeon; Crystallization; Exodeoxyribonuclease; Sulfolobus tokodaii; X-Ray Diffraction 1. Introduction formational change upon protein binding that permits complex formation and activation of attacking water, A variety of mechanisms exist to repair damaged DNA leading to incision, in the presence of Mg2+ [10,11].
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0089535 A1 Yamashiro Et Al
    US 2013 0089535A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0089535 A1 Yamashiro et al. (43) Pub. Date: Apr. 11, 2013 (54) AGENT FOR REDUCING ACETALDEHYDE Publication Classification NORAL CAVITY (51) Int. Cl. (75) Inventors: Kan Yamashiro, Kakamigahara-shi (JP); A68/66 (2006.01) Takahumi Koyama, Kakamigahara-shi A638/51 (2006.01) (JP) A61O 11/00 (2006.01) A638/44 (2006.01) Assignee: AMANOENZYME INC., Nagoya-shi (52) U.S. Cl. (73) CPC. A61K 8/66 (2013.01); A61K 38/44 (2013.01); (JP) A61 K38/51 (2013.01); A61O II/00 (2013.01) (21) Appl. No.: 13/703,451 USPC .......... 424/94.4; 424/94.5; 435/191: 435/232 (22) PCT Fled: Jun. 7, 2011 (57) ABSTRACT Disclosed herein is a novel enzymatic agent effective in (86) PCT NO.: PCT/UP2011/062991 reducing acetaldehyde in the oral cavity. It has been found S371 (c)(1), that an aldehyde dehydrogenase derived from a microorgan (2), (4) Date: Dec. 11, 2012 ism belonging to the genus Saccharomyces and a threonine aldolase derived from Escherichia coli are effective in reduc (30) Foreign Application Priority Data ing low concentrations of acetaldehyde. Therefore, an agent for reducing acetaldehyde in the oral cavity is provided, Jun. 19, 2010 (JP) ................................. 2010-140O26 which contains these enzymes as active ingredients. Patent Application Publication Apr. 11, 2013 Sheet 1 of 2 US 2013/0089535 A1 FIG 1) 10.5 1 0 9.9.5 8. 5 CONTROL TA AD (BSA) ENZYME Patent Application Publication Apr. 11, 2013 Sheet 2 of 2 US 2013/0089535 A1 FIG 2) 110 the CONTROL (BSA) 100 354.
    [Show full text]
  • The Rnase H-Like Superfamily: New Members, Comparative Structural Analysis and Evolutionary Classification Karolina A
    4160–4179 Nucleic Acids Research, 2014, Vol. 42, No. 7 Published online 23 January 2014 doi:10.1093/nar/gkt1414 The RNase H-like superfamily: new members, comparative structural analysis and evolutionary classification Karolina A. Majorek1,2,3,y, Stanislaw Dunin-Horkawicz1,y, Kamil Steczkiewicz4, Anna Muszewska4,5, Marcin Nowotny6, Krzysztof Ginalski4 and Janusz M. Bujnicki1,3,* 1Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland, 2Department of Molecular Physiology and Biological Physics, University of Virginia, 1340 Jefferson Park Avenue, Charlottesville, VA USA-22908, USA, 3Bioinformatics Laboratory, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Umultowska 89, PL-61-614 Poznan, Poland, 4Laboratory of Bioinformatics and Systems Biology, Centre of New Technologies, University of Warsaw, Zwirki i Wigury 93, PL-02-089 Warsaw, Poland, 5Institute of Biochemistry and Biophysics PAS, Pawinskiego 5A, PL-02-106 Warsaw, Poland and 6Laboratory of Protein Structure, International Institute of Molecular and Cell Biology, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland Received September 23, 2013; Revised December 12, 2013; Accepted December 26, 2013 ABSTRACT revealed a correlation between the orientation of Ribonuclease H-like (RNHL) superfamily, also called the C-terminal helix with the exonuclease/endo- the retroviral integrase superfamily, groups together nuclease function and the architecture of the numerous enzymes involved in nucleic acid metab- active site. Our analysis provides a comprehensive olism and implicated in many biological processes, picture of sequence-structure-function relation- including replication, homologous recombination, ships in the RNHL superfamily that may guide func- DNA repair, transposition and RNA interference.
    [Show full text]
  • The Classification of Esterases: an Important Gene Family Involved in Insecticide Resistance - a Review
    Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 107(4): 437-449, June 2012 437 The classification of esterases: an important gene family involved in insecticide resistance - A Review Isabela Reis Montella1,2, Renata Schama1,2,3/+, Denise Valle1,2,3 1Laboratório de Fisiologia e Controle de Artrópodes Vetores, Instituto Oswaldo Cruz-Fiocruz, Av. Brasil 4365, 21040-900 Rio de Janeiro, RJ, Brasil 2Instituto de Biologia do Exército, Rio de Janeiro, RJ, Brasil 3Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular, Rio de Janeiro, RJ, Brasil The use of chemical insecticides continues to play a major role in the control of disease vector populations, which is leading to the global dissemination of insecticide resistance. A greater capacity to detoxify insecticides, due to an increase in the expression or activity of three major enzyme families, also known as metabolic resistance, is one major resistance mechanisms. The esterase family of enzymes hydrolyse ester bonds, which are present in a wide range of insecticides; therefore, these enzymes may be involved in resistance to the main chemicals employed in control programs. Historically, insecticide resistance has driven research on insect esterases and schemes for their classification. Currently, several different nomenclatures are used to describe the esterases of distinct species and a universal standard classification does not exist. The esterase gene family appears to be rapidly evolving and each insect species has a unique complement of detoxification genes with only a few orthologues across species. The examples listed in this review cover different aspects of their biochemical nature. However, they do not appear to contribute to reliably distinguish among the different resistance mechanisms.
    [Show full text]
  • Integrated Molecular Profiling for Analyzing and Predicting Therapeutic Mechanism, Response, Biomarker and Target
    INTEGRATED MOLECULAR PROFILING FOR ANALYZING AND PREDICTING THERAPEUTIC MECHANISM, RESPONSE, BIOMARKER AND TARGET Jia Jia (B. Sci & M. Sci, Zhejiang University) A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF PHARMACY NATIONAL UNIVERSITY OF SINGAPORE 2010 Acknowledgements ACKNOWLEDGEMENTS I would like to deeply thank Professor Chen Yu Zong, for his constant encouragement and advice during the entire period of my postgraduate studies. In particular, he has guided me to make my research applicable to the real world problem. This work would not have been possible without his kindness in supporting me to shape up the manuscript for publication. I am also tremendously benefited from his profound knowledge, expertise in scientific research, as well as his enormous support, which will inspire and motivate me to go further in my future professional career. I am also grateful to our BIDD group members for their insight suggestions and collaborations in my research work: Dr. Tang Zhiqun, Ms. Ma Xiaohua, Mr. Zhu Feng, Ms. Liu Xin, Ms. Shi Zhe, Dr. Cui Juan, Mr. Tu Weimin, Dr. Zhang Hailei, Dr. Lin Honghuang, Dr. Liu Xianghui, Dr. Pankaj Kumar, Dr Yap Chun wei, Ms. Wei Xiaona, Ms. Huang Lu, Mr. Zhang Jinxian, Mr. Han Bucong, Mr. Tao Lin, Dr. Wang Rong, Dr. Yan Kun. I thank them for their valuable support and encouragement in my work. Finally, I owe my gratitude to my parents for their forever love, constant support, understanding, encouragement and strength throughout my life. A special appreciation goes to all for love and support. Jia Jia August 2010 I Table of Contents TABLE OF CONTENTS 1.1 Overview of mechanism and strategies of molecular-targeted therapeutics ...................................
    [Show full text]
  • Ribonuclease and Deoxyribonuclease Activities in Experimental and Human Tumors by the Histochemical Substrate Film Method*
    Ribonuclease and Deoxyribonuclease Activities in Experimental and Human Tumors by the Histochemical Substrate Film Method* R. DAOUSTJANDHARUKOAMANOÕ (Laboratoires de Recherche, Institut du Cancer de Montréal,Hôpital Notre-Dame et Universitéde Montréal,Montréal,Canada) SUMMARY The ribonuclease and deoxyribonuclease activities of 65 experimental and human tu mors (32 different types) have been examined by histochemical substrate film methods. A same general pattern was obtained for the distribution of both nucleases in the various types of experimental and human tumors. The connective tissue stroma and the necrotic regions of the tumor masses showed various levels of nuclease activity, whereas the neoplastic cells showed no demonstrable activity. It appears that deficien cies in ribonuclease and deoxyribonuclease activities represent general properties of cancer cells. The possible significance of the losses of nuclease activities in carcinogenesis is dis cussed. Studies on nucleases by histochemical methods MATERIALS AND METHODS have shown that losses of ribonuclease (RNase) The experimental tumors used in the present and deoxyribonuclease (DNase) activities take study were mostly rat, mouse, and hamster trans- place in rat liver during azo-dye carcinogenesis (1, plantable tumors (see Table 1). The tumor-bearing 6). The loss of RNase activity is progressive and animals were obtained from commercial or private occurs before parenchymal cells become cancerous, sources, and the tumors were used as supplied or whereas the loss of DNase activity is abrupt and closely associated with the neoplastic transforma TABLE1 tion of parenchymal cells. EXPERIMENTALTUMORS If a loss of RNase or DNase activity plays an important role in tumor formation, the lack of SpeciesRat"""MouseHamsterTumorPrimary demonstrable nuclease activity observed in rat hepatomaNovikoff primary hepatomas should also be observed in a hepatomaWalker variety of tumors.
    [Show full text]
  • Rnase I Manual
    Manual RNase I For Research Use Only. Not for use in diagnostic procedures. RNase I is part of the Epicentre™ product line, known for its unique genomics kits, enzymes, and reagents which offer high quality and reliable performance. Manual RNase I Contents 1. Introduction .......................................................................................................................................3 2. Product designations and kit components ....................................................................................3 3. Product specifications ......................................................................................................................3 4. Protocol for removing RNA from DNA preparations .....................................................................4 5. References .........................................................................................................................................4 6. Further support .................................................................................................................................4 Manual RNase I 1. Introduction RNase I preferentially degrades single-stranded RNA to individual nucleoside 3′ monophosphates by cleaving every phosphodiester bond.1 By comparison, other ribonucleases cleave only after specific residues (e.g., RNase A cleaves 3′ to pyrimidine residues). Thus, RNase I is useful for removing RNA from DNA preparations,2 detecting mismatches in RNA:RNA and RNA:DNA hybrids2,3 and analysing and quantifying RNA in ribonuclease
    [Show full text]
  • Supplementary Materials
    Supplementary Materials COMPARATIVE ANALYSIS OF THE TRANSCRIPTOME, PROTEOME AND miRNA PROFILE OF KUPFFER CELLS AND MONOCYTES Andrey Elchaninov1,3*, Anastasiya Lokhonina1,3, Maria Nikitina2, Polina Vishnyakova1,3, Andrey Makarov1, Irina Arutyunyan1, Anastasiya Poltavets1, Evgeniya Kananykhina2, Sergey Kovalchuk4, Evgeny Karpulevich5,6, Galina Bolshakova2, Gennady Sukhikh1, Timur Fatkhudinov2,3 1 Laboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, Moscow, Russia 2 Laboratory of Growth and Development, Scientific Research Institute of Human Morphology, Moscow, Russia 3 Histology Department, Medical Institute, Peoples' Friendship University of Russia, Moscow, Russia 4 Laboratory of Bioinformatic methods for Combinatorial Chemistry and Biology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia 5 Information Systems Department, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow, Russia 6 Genome Engineering Laboratory, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia Figure S1. Flow cytometry analysis of unsorted blood sample. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S2. Flow cytometry analysis of unsorted liver stromal cells. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S3. MiRNAs expression analysis in monocytes and Kupffer cells. Full-length of heatmaps are presented.
    [Show full text]
  • HOXB6 Homeo Box B6 HOXB5 Homeo Box B5 WNT5A Wingless-Type
    5 6 6 5 . 4 2 1 1 1 2 4 6 4 3 2 9 9 7 0 5 7 5 8 6 4 0 8 2 3 1 8 3 7 1 0 0 4 0 2 5 0 8 7 5 4 1 1 0 3 6 0 4 8 3 7 4 7 6 9 6 7 1 5 0 8 1 4 1 1 7 1 0 0 4 2 0 8 1 1 1 2 5 3 5 0 7 2 6 9 1 2 1 8 3 5 2 9 8 0 6 0 9 5 1 9 9 2 1 1 6 0 2 3 0 3 6 9 1 6 5 5 7 1 1 2 1 1 7 5 4 6 6 4 1 1 2 8 4 7 1 6 2 7 7 5 4 3 2 4 3 6 9 4 1 7 1 3 4 1 2 1 3 1 1 4 7 3 1 1 1 1 5 3 2 6 1 5 1 3 5 4 5 2 3 1 1 6 1 7 3 2 5 4 3 1 6 1 5 3 1 7 6 5 1 1 1 4 6 1 6 2 7 2 1 2 e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S HOXB6 homeo box B6 HOXB5 homeo box B5 WNT5A wingless-type MMTV integration site family, member 5A WNT5A wingless-type MMTV integration site family, member 5A FKBP11 FK506 binding protein 11, 19 kDa EPOR erythropoietin receptor SLC5A6 solute carrier family 5 sodium-dependent vitamin transporter, member 6 SLC5A6 solute carrier family 5 sodium-dependent vitamin transporter, member 6 RAD52 RAD52 homolog S.
    [Show full text]
  • Supplemental Methods
    Supplemental Methods: Sample Collection Duplicate surface samples were collected from the Amazon River plume aboard the R/V Knorr in June 2010 (4 52.71’N, 51 21.59’W) during a period of high river discharge. The collection site (Station 10, 4° 52.71’N, 51° 21.59’W; S = 21.0; T = 29.6°C), located ~ 500 Km to the north of the Amazon River mouth, was characterized by the presence of coastal diatoms in the top 8 m of the water column. Sampling was conducted between 0700 and 0900 local time by gently impeller pumping (modified Rule 1800 submersible sump pump) surface water through 10 m of tygon tubing (3 cm) to the ship's deck where it then flowed through a 156 µm mesh into 20 L carboys. In the lab, cells were partitioned into two size fractions by sequential filtration (using a Masterflex peristaltic pump) of the pre-filtered seawater through a 2.0 µm pore-size, 142 mm diameter polycarbonate (PCTE) membrane filter (Sterlitech Corporation, Kent, CWA) and a 0.22 µm pore-size, 142 mm diameter Supor membrane filter (Pall, Port Washington, NY). Metagenomic and non-selective metatranscriptomic analyses were conducted on both pore-size filters; poly(A)-selected (eukaryote-dominated) metatranscriptomic analyses were conducted only on the larger pore-size filter (2.0 µm pore-size). All filters were immediately submerged in RNAlater (Applied Biosystems, Austin, TX) in sterile 50 mL conical tubes, incubated at room temperature overnight and then stored at -80oC until extraction. Filtration and stabilization of each sample was completed within 30 min of water collection.
    [Show full text]
  • Production of L-Carnitine by Secondary Metabolism of Bacteria Vicente Bernal, Ángel Sevilla, Manuel Cánovas and José L Iborra*
    Microbial Cell Factories BioMed Central Review Open Access Production of L-carnitine by secondary metabolism of bacteria Vicente Bernal, Ángel Sevilla, Manuel Cánovas and José L Iborra* Address: Department of Biochemistry and Molecular Biology B and Immunology, Campus of Espinardo, University of Murcia, E-30100, Spain Email: Vicente Bernal - [email protected]; Ángel Sevilla - [email protected]; Manuel Cánovas - [email protected]; José L Iborra* - [email protected] * Corresponding author Published: 2 October 2007 Received: 19 July 2007 Accepted: 2 October 2007 Microbial Cell Factories 2007, 6:31 doi:10.1186/1475-2859-6-31 This article is available from: http://www.microbialcellfactories.com/content/6/1/31 © 2007 Bernal et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract The increasing commercial demand for L-carnitine has led to a multiplication of efforts to improve its production with bacteria. The use of different cell environments, such as growing, resting, permeabilized, dried, osmotically stressed, freely suspended and immobilized cells, to maintain enzymes sufficiently active for L-carnitine production is discussed in the text. The different cell states of enterobacteria, such as Escherichia coli and Proteus sp., which can be used to produce L- carnitine from crotonobetaine or D-carnitine as substrate, are analyzed. Moreover, the combined application of both bioprocess and metabolic engineering has allowed a deeper understanding of the main factors controlling the production process, such as energy depletion and the alteration of the acetyl-CoA/CoA ratio which are coupled to the end of the biotransformation.
    [Show full text]